ABOUT US

Who we are

Adjuvatis develops, manufactures biocompatible delivery system called i-Particles® and proposes a formulation service based on its technology.

Our Mission

Providing scientists and pharmaceutical companies safer, more stable and effective formulations thanks to i-Particles® technology.

Our Advisory Board

Adjuvatis team is built around valuable experts, gathering insights into scientific orientations, business development and customer-dedicated marketing strategy.

Our Network

From extending our technological network to supporting innovation, Adjuvatis scientific partners widen our panel of expertise and contribute to strive for excellence.

TECHNOLOGY

Fully metabolizable i-Particles

i-Particles® technology originates from the fundamental statement that pharmaceuticals should never involve harmful by-products and only focus on patient safety. Starting from this idea, Adjuvatis technology is led by one main concept: safe-by-design.

i-Particles Technology

Synthetized by an eco-friendly and additive-free process, i-Particles® exclusively consist in a biodegradable polymer and selected active pharmaceutical ingredients.

Strategic solutions

Increasing pharmaceutical efficacy and safety while reducing risk profile and costs, and extending product life cycle.

Expertise

Following 10 years of research and supported by a multi-skilled team, Adjuvatis will push forward your active’s intrinsic properties and potentiate your product development.

APPLICATIONS

i-Particles - Driver of innovation

i-Particles® formulations have demonstrated enhancements in healthcare and technological fields, especially vaccines, antibody generation and drug delivery. Adjuvatis is constantly extending the scope of applications to reach new markets, support customer developments and prove once again the versatility of its technology.

01.

Vaccine Development

i-Particles® increase immunogenicity and improve stability of vaccines formulations.

02.

Antibody Generation

Reduce antibodies production costs and improve their affinity using i-Particles®.

03.

Drug Delivery System

Formulating with i-Particles® offer protection and sustained delivery for your active pharmaceutical ingredient.

PRODUCTS & SERVICES

i-Particles-based formulations & in-depth characterizations

Adjuvatis provides a full formulation development and characterization services in a rigorous quality framework.

INNOVATIVE RESEARCH

What are you waiting for?

Discover our fully dedicated and quality-oriented ways of working, integrating both skills and experience to provide cutting-edge service for formulation development of biopharmaceuticals.

DIRECT ACCESS

Meet Our Team

Our dynamic team, supported by a referent advisory board and external experts, qualifies for expertise in Chemistry, Biochemistry and Biology, Manufacturing and Partnering. By working collaboratively, we are committed to innovate for your therapeutic products developments.

STRATEGIC SOLUTIONS

Why formulate with Adjuvatis?

Overcome technical obstacles and reach new markets.

OUR NETWORK

Expertise optimise us

Feel free to contact us to explore licensing opportunities, collaborative researches, or commercial partnerships.

LATEST NEWS

Adjuvatis Live

Follow our participation to scientific events, symposium and congresses.
Discover our press releases and publications.

Custom formulations adapted to poorly water-soluble active ingredients

  • By Charlotte PRIMARD
  • on Mar 24, 2021
Anyone working on the development of active ingredients knows the difficulties encountered during this lengthy process, right from the R&D.
Read More

Versatile formulation of active ingredients, adapted to poorly water-soluble or rapidly metabolised drugs, allowing their solubilisation, protection and targeted delivery

  • By Charlotte PRIMARD
  • on Mar 02, 2021
Interested in Adjuvatis’ drug formulation technology but want to learn more? Meet us at the Forum de la Recherche en.
Read More

Improving antibiotic delivery in Staphylococcus aureus biofilms

  • By Charlotte PRIMARD
  • on Jan 13, 2021
Da Costa D, et al., Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms.
Read More
JOIN US

Welcome in Lyon

At the heart of the Biodistrict Lyon Gerland, a hotspot for world leaders in Life Sciences in vicinity to institutional, academic and private companies, Adjuvatis benefits from a unique environment in terms of technological innovation.